우정바이오

215380· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩2,395+5.04%

2026-08-04

Financials

Valuation Metrics

우정바이오's Market Cap is ₩403B. At end of 2025 it was ₩296B. Ranked #1875 of 2,436 in KR market (top 77%), #1160 of 1,649 on KOSDAQ (top 70%), #202 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 86%) by Market Cap.

Investment Metrics(as of 2026-08-04)

Metric	Value	Rank
Size
Market Cap	40.31B KRW	KR#1,875/2,436 Sec#202/234
Revenue	40.30B KRW	KR#1,896/2,436 Sec#132/234
Net Income	-3.68B KRW	KR—/2,436 Sec—/234
Total Assets	121.62B KRW	KR#1,609/2,436 Sec#130/234
Net Assets	23.17B KRW	KR#2,238/2,436 Sec#207/234
Employees	151	KR#1,319/2,436 Sec#107/234
Value
P/B	1.74x	KR#1,888/2,436 Sec#138/234
P/S	1.00x	KR#1,391/2,436 Sec#82/234
FCF Yield	-2.19%	KR—/2,436 Sec—/234
Profitability
ROE	-15.87%	KR#2,012/2,436 Sec#159/234
ROA	-3.02%	KR#1,761/2,436 Sec#129/234
Op. Margin	-5.14%	KR#1,868/2,436 Sec#126/234
Revenue Growth	32.69%	KR#445/2,436 Sec#38/234
Earnings Growth	-1181.19%	KR#1,703/2,436 Sec#117/234
Financial Health
Debt Ratio	524.97%	KR#2,310/2,436 Sec#226/234
Total Debt	82.92B KRW	KR#787/2,436 Sec#52/234
FCF	-884.5M KRW	KR#1,273/2,436 Sec#96/234
Cash	1.76B KRW	KR#2,269/2,436 Sec#217/234
Current Ratio	0.80x	KR#2,034/2,436 Sec#194/234
Performance
1Y Return	49.50%	KR#240/2,436 Sec#19/234
1M Return	-1.64%	KR#1,059/2,436 Sec#102/234
From 52W High	-47.19%	KR#1,065/2,436 Sec#87/234
1Y MDD	-38.84%	KR#483/2,436 Sec#38/234
Trading
Volume	11,961 shares	KR#2,065/2,436 Sec#205/234
Foreign Own.	7.83%	KR#574/2,436 Sec#53/234
Per Share
EPS	-218 KRW	KR—/2,436 Sec—/234
BPS	1,390 KRW	KR#2,190/2,436 Sec#193/234

Company Info

CEO 천희정

Employees 151

Founded 2015

HQ 경기도 화성시, KR

Website www.woojungbio.kr

동사는 1989년 설립되어 2015년 코스닥 상장한 바이오 전문기업으로, 바이오사업과 감염관리사업을 영위함. 바이오사업은 2021년 민간 최초로 구축한 우정바이오 신약클러스터를 통해 비임상CRO서비스와 비바리움 운영사업을 진행하며, 감염관리사업은 과산화수소 증기 멸균법 기반 공간멸균 토탈시스템을 제공함. 축적된 현장경험과 기술력으로 국내 전임상CRO 업계 1위 기업 위상을 구축하고, 글로벌 신약개발 생태계 조성에 주력하고 있음. 우정바이오는 2015년에 설립되었으며 경기도 화성시에 본사를 두고 있습니다.